Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Hepatitis 1Esophageal Stenosis 1Esophageal Neoplasms 1Chemical and Drug Induced Liver Injury 1Brain Injuries 1

Interventions

Cyclophosphamide 5Vincristine 4Doxorubicin 3fludarabine phosphate 2Psychiatric Rehabilitation 2Prednisone 2Prednisolone 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Flow Cytometry 2Etoposide 2Cytarabine 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2sargramostim 1ruxolitinib 1nelarabine 1motesanib diphosphate 1carbendazim 1Transplantation 1Therapeutics 1Steroids 1Sensitivity and Specificity 1S-1,2-dichlorovinyl-N-acetylcysteine 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Steroids × Clear all
NCT03613428 2018-08-03

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Sichuan University

Phase 1/2 Unknown
12 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡